Achieve Life Sciences, Inc. (ACHV) income statement
ACHVNasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31Also trades as QUIT
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 4/30
$6.72+0.34 (+5.33%)
Close on Nov 6, 2026Market cap $691.51MP/E –Yield –
Achieve Life Sciences, Inc. income statement
Ratios
Latest available, balances at Jun 30, 2026
Profitability, FY
- Gross margin
- –
- Operating margin
- –
- Net margin
- –
- Return on equity, FY2025
- -257.7%
Financial strength
- Current ratio
- 0.95
- Debt to equity
- –
- Debt to assets
- –
- Cash to current liabilities
- 24.3%
Valuation
- P/E ratio
- –
- Price to sales
- –
- Price to book
- –
- Dividend yield
- –
See a number that looks wrong?